One of ViiV Healthcare’s two-drug HIV therapies – Dovato – has been approved in Japan, providing a new treatment option for the country’s 30,000 or so people with HIV. Dovato (dolutegravir ...

Meanwhile, although patients switching to both drugs from their old regimen saw an increase in weight, it was significantly less with Dovato compared to Biktarvy, with average gains of 1.81kg and ...